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Mammalian Cells to Low Doses of Tritium
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Radioactive compounds incorporated in tissues can have bi-
ological effects resulting from energy deposition in subcellular
compartments. We addressed the genetic consequences of [3H]
or [14C]thymidine incorporation into mammalian DNA. Low
doses of [3H]thymidine in CHO cells led to enhanced sensitiv-
ity compared with [14C]thymidine. Compared with wild-type
cells, homologous recombination (HR)-deficient cells were
more sensitive to lower doses of [3H]thymidine but not to any
dose of [14C]thymidine. XRCC4-defective cells, however, were
sensitive to both low and high doses of [3H] and
[14C]thymidine, suggesting introduction of DNA double-strand
breaks, which were confirmed by -H2AX focus formation.
While  rays induced measurable HR only at toxic doses, sub-
lethal levels of [3H] or [14C]thymidine strongly induced HR.
The level of stimulation was in an inverse relationship to the
emitted energies. The RAD51 gene conversion pathway was
involved, because [3H]thymidine induced RAD51 foci, and
[3H]thymidine-induced HR was abrogated by expression of
dominant negative RAD51. In conclusion, both HR and non-
homologous end-joining pathways were involved after labeled
nucleotide incorporation (low doses); genetic effects were neg-
atively correlated with the energy emitted but were positively
correlated with the energy deposited in the nucleus, suggesting
that low-energy -particle emitters, at non-toxic doses, may
induce genomic instability.  2008 by Radiation Research Society
INTRODUCTION
Environmental concerns have been raised by the use of
both naturally occurring and synthetic radioactive com-
pounds, which can cause external or internal exposure to
ionizing radiation. In the case of external exposure, only
radioactive sources emitting sufficiently penetrating radia-
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Avenue A. Fliche, 34295 Montpellier Cedex 5, France.
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tion reach cellular targets and cause biological effects.
However, radioactive compounds emitting rays with low
penetrating energy can also have a biological impact if they
are incorporated into cells and tissues, causing in situ self-
irradiation. Moreover, the low penetration becomes an am-
plifying factor because energy is focused in the vicinity of
the incorporated isotope.
In the present work, we address the genetic consequences
of incorporation of non-lethal amounts of labeled thymidine
into mammalian cell DNA. Because of the low energy de-
position and low penetration depth, 3H-labeled nucleotides
release their energy to any structures in proximity (e.g.
DNA). We compared the effects of [3H]thymidine on cell
viability, DNA double-strand break (DSB) formation, and
homologous recombination (HR) with those of thymidine
labeled with 14C. Since the 3H and 14C isotopes emit dif-
ferent energies—0.019 MeV and 0.157 MeV, respective-
ly—their actual energy depositions in the cell nucleus are
different, corresponding to 68% and 19%, respectively (1).
This provides a model to evaluate biological effects as a
function of the energy actually deposited in the nucleus.
Lethal and genetic effects induced by 3H have been de-
scribed for mammalian cells (2–9). HR induced by
[3H]uracil or tritiated water have been described in yeast
(10, 11). Using updated methods, cellular responses to la-
beled thymidine can now be addressed at the molecular
level, and the pathways involved can be characterized in
mammalian cells.
We report here the induction of DSBs by sublethal doses
of incorporated labeled thymidine, as revealed by -H2AX
focus formation. Since DSBs can be repaired by non-ho-
mologous end joining (NHEJ) or HR in mammalian cells,
we first studied the consequences of a defect either in HR
or in XRCC4, a component of the primary NHEJ repair
pathway, on cell survival after labeled thymidine incorpo-
ration. We then analyzed the molecular and genetic effects
of labeled thymidine incorporation on HR.
To analyze HR at the molecular level, we used a well-
characterized intrachromosomal substrate. Strategies em-
ploying such substrates have been widely used in different
cell lines, in different genetic backgrounds, and at different
loci. Thus, although there might be hot and cold regions
for HR, and that generalization to the genome is by extrap-
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olation, this strategy is the most precise to monitor HR at
defined, and controlled, molecular levels. The influence of
the HR protein RAD51 was analyzed using a dominant
negative form of RAD51 and measuring the induction of
RAD51 foci. We also compared the lethal effects and HR
induced by [3H]thymidine incorporation, [14C]thymidine in-
corporation, and external exposure to 137Cs  radiation,
which emits high-energy (0.662 MeV) and highly pene-
trating  rays.
MATERIALS AND METHODS
Cell Lines
We used a collection of Chinese hamster cell lines containing an in-
trachromosomal recombination substrate as depicted in Fig. 1A (12). This
substrate contains a direct repeat of two inactive neomycin-resistant
(NEO) genes, which can be restored to a functional NEO gene through
recombination. The parental cells are sensitive to G418, but the recom-
binants are G418-resistant (12). Cells were maintained at 37C with 95%
air/5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum.
The CHO-DRA10 cell line is derived from the CHO-K1 hamster line and
harbors an intrachromosomal substrate that monitors HR (12). SM-RAD51-
4 is a CHO-DRA10 cell line that expresses the dominant negative SMRAD51
gene (Fig. 1B), which inhibits spontaneous as well as induced HR (13). Thus
both CHO-DRA10 and SMRAD51-4 cells bear the same recombination sub-
strate at the same locus (Fig. 1B). The XR-1 hamster cell line is defective
for the XRCC4 gene, a co-factor of DNA ligase IV that is involved in the
late steps of NHEJ, and is highly sensitive to ionizing radiation (14). X4V
is an XR-1 line complemented with human XRCC4 cDNA (15). Information
on all the cell lines is summarized in Fig. 1C.
Radioactive Labeling of Cells
[Methyl-3H]dThd (45 Ci/mmol, 1.67 TBq/mmol) or [methyl-14C]dThd
(58 mCi/mmol, 2.15 TBq/mmol), purchased from Amersham (GE Health-
care Europe, Orsay, France), was diluted in regular medium. Cells were
contaminated during asynchronous exponential growth at the same stoi-
chiometric concentration (0.1 mM) but at various specific activities (0.05–
5 Ci/ml, 1.85–185 kBq/ml). Cells were incubated for 20 h at 37C with
95% air/5% CO2, at which time incorporation reached a plateau; over
95% of cells contained labeled nucleotides. Radioactive medium was then
discarded, and cells were washed twice in phosphate-buffered saline be-
fore processing (Fig. 1D). Experiments were repeated at least three times.
Gamma Irradiation
Cells in PBS were irradiated during exponential, asynchronous growth
using a 137Cs irradiator (2 Gy/min) at the indicated doses and then were
incubated in DMEM at 37C for 20 h before processing. Experiments
were repeated three times.
Measurement of Homologous Recombination
Cells were trypsinized, counted and divided into three fractions. The
first fraction was used to measure the incorporation of labeled nucleo-
tides, the second was used to measure the colony-forming efficiency, and
the third was plated with 1 mg/ml G418 to measure the recombination
frequency. Experiments were repeated more than three times.
Measurement of Labeled Nucleotides Incorporated into DNA
Cells were suspended, and DNA was precipitated in ice-cold 10%
trichloroacetic acid (TCA). Precipitated DNA was recovered on GF/C
filters (Whatman) that were then washed with 10% and 5% TCA. Incor-
poration of [3H] or [14C]thymidine into DNA was determined by liquid
scintillation counting of the filters. The incorporation rate was expressed
as disintegrations per minute (dpm) per 106 cells. We estimated the dose
delivered into each nucleus using conversion factors described elsewhere
(1). For 3H incorporated into the nucleus, the conversion factor is 1 dis-
integration  2.7  103 Gy; for 14C, 1 disintegration  1.9  103 Gy.
The doses were calculated for a 20-h incorporation.
Western Blotting and Immunofluorescence
All cell extraction steps were performed at 4C. After cells were
washed with PBS, they were suspended in lysis buffer (25 mM Tris, pH
7.5, 5 mM EDTA, 600 mM NaCl, 1 mM DTT, 0.1% NP40, 5 g/ml
leupeptin, 2 M pepstatin, 1 mM PMSF) and were incubated for 30 min
on ice. Extracts were centrifuged for 30 min at 15,000g, the supernatant
was recovered and protein concentration was determined using the Bio-
Rad protein assay. Boiled samples (50 g/well) were loaded on a 10%
polyacrylamide gel for electrophoresis in the presence of SDS. After mi-
gration, the proteins were electrotransferred to a nitrocellulose membrane
and probed with specific anti-human RAD51 antibodies (Oncogene Re-
search). Standard procedures were used for electrophoresis, transfer and
Western blotting. Visualization was done with an ECL detection kit
(Amersham).
The RAD51 foci were analyzed as described previously (16) using
anti-RAD51 antibody (Pharmingen, VWR, France). The -H2AX foci
were analyzed as described previously (17) using anti-phospho-H2AX
antibody (Upstate, Lake Placid, NY). Cells were incubated for 20 h with
[methyl-3H]dThd or [methyl-14C]dThd and were then fixed (methanol/
acetone) and stained. Experiments were repeated three times with a min-
imum of 100 nuclei per incorporated dose scored in each experiment.
Cell Cycle Analysis
Trypsinized cells were collected by centrifugation (5 min at 2000g),
resuspended in 500 l PBS, and fixed by adding 1.5 ml cold ethanol.
Cells were then treated with propidium iodide (50 g/ml) and RNase (25
g/ml). DNA content was measured by flow cytometry (FACSCalibur,
Becton Dickinson France SAS, Le Pont-De-Claix, France). For each
aquisition, 10,000 and 20,000 cells were scored for 137Cs external  ra-
diation and labeled nucleotide incorporation, respectively. Cell cycle dis-
tributions were analyzed using the Dean-Jett-Fox model on FlowJo soft-
ware (TreeStar, Inc. Ashland, OR). Dead cells, debris and doublets were
excluded from the data analysis.
Data Plotting and Statistical Analysis
In contrast to  radiation, nucleotide incorporation varies among repeated
experiments. As a consequence, averages and standard deviations cannot be
calculated and plotted; all data were graphed as scatter plots. Then we cal-
culated the Spearman’s Rho rank correlation coefficient (rs) for the relation-
ship between two non-normally distributed variables. This provided for anal-
ysis of the nonlinear relationship between radioisotope cellular contamination
and the biological end points (colony-forming efficiency, HR, foci). All re-
sults showed a significant Spearman’s Rho rank correlation coefficient. Re-
gression curves were calculated using a Gaussian convolution data transfor-
mation of the non-linear distributions. Comparisons between regression
curves used the Wilcoxon matched pairs test. All analyses were done using
Prism (GraphPad Software, Inc. San Diego, CA).
RESULTS
Cell Cycle Distributions after [14C] or [3H]Thymidine
Incorporation
Cells were treated with [3H]thymidine or [14C]thymidine
(Fig. 1) and analyzed using a fluorescence-activated cell
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FIG. 1. Cell lines used. Panel A: Homologous recombination substrate. This substrate contains a direct repeat of
two inactive neomycin-resistant (NEO) genes. The parental cells are sensitive to G418. Recombination restores a
functional NEO gene. Recombinants are resistant to G418 (12). Panel B: Expression of the RAD51 dominant negative
SMRAD51, measured by Western blot analysis (13). The two bands indicate SMRAD51 expression. Panel C: Names
and characteristics of the different cell lines used here. Panel D: Experimental design. Cells were cultured in the
presence of different specific activities of [3H] or [14C]thymidine. The final concentration of thymidine was kept
constant using cold thymidine. After 20 h of incubation, when incorporation reached a plateau, over 95% of cells
contained labeled nucleotides. Incorporated radioactivity was counted in the trichloroacetic acid (TCA) precipitate.
Viability (colony-forming efficiency) and recombination frequency were measured.
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FIG. 2. Effect of incorporation of labeled thymidine (3H or 14C) on cell cycle progression. Cell cycle phases were
determined by DNA content measured by flow cytometry for cells harvested immediately after incorporation of
[3H]thymidine and [14C]thymidine. For external  radiation (137Cs), cell cycle phases were determined in cells har-
vested 20 h after irradiation. Percentages of cell in G1, S and G2/M are indicated on each profile. Cell cycle analyses
were performed in three independent experiments.
sorter (FACS) to measure the impact of the radioactivity on
cell cycle distributions. In wild-type CHO-DRA10 cells, no
modifications in cell cycle distributions were recorded for
incorporation of [3H] or [14C]thymidine up to 1.94 or 1.59
Gy/nucleus, respectively. In contrast, 2 Gy of  rays gen-
erated marked G2 arrest 20 h after irradiation (Fig. 2). How-
ever, increasing the incorporated doses of the -particle
emitters generated transient blocks in G2/M. The G2 blocks
were detectable for doses of 3.93 and 4.18 Gy/nucleus of
[3H] and [14C]thymidine, respectively. Lower doses of la-
beled nucleotide incorporation were not sufficient to pro-
voke a detectable cell cycle arrest.
Cell Viability after [14C] or [3H]Thymidine Incorporation:
Impact of Low and Higher Incorporated Doses
[3H]Thymidine and [14C]thymidine exhibited comparable
LD50s of 3.24 and 2.98 Gy/nucleus, respectively (Fig. 3A
and B). However, the dose–response curve was biphasic for
[3H]thymidine and linear for [14C]thymidine. At the lowest
doses (	1 Gy/nucleus), [3H]thymidine was significantly
more toxic than [14C]thymidine (P 	 0.0001; compare Fig.
3A and B). At 0.50 Gy/nucleus, the mean viabilities were
69% for [3H]thymidine and 90% for [14C]thymidine, and
the LD30s were 0.47 Gy/nucleus and 1.53 Gy/nucleus for
incorporated [3H] and [14C]thymidine, respectively.
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FIG. 3. Effect of incorporation of labeled thymidine (3H or 14C) on survival. Panel A: [3H]Thymidine incorporation in CHO-DRA10 and SMRAD51
cells. A decrease in colony-forming efficiency (CFE) is significantly linked to [3H]thymidine incorporation in both CHO-DRA10 and SMRAD51 cells
(P 	 0.0001). Panel B: [14C]Thymidine incorporation in CHO-DRA10 and SMRAD51 cells. A decrease in colony-forming efficiency is significantly
linked to [14C]thymidine incorporation in both CHO-DRA10 and SMRAD51 cells (P 	 0.0001). Panel C: [3H]Thymidine incorporation in xrcc4
(NHEJ-deficient) and xrcc4
 (control) cells. A decrease in colony-forming efficiency is significantly linked to [3H]thymidine incorporation in XR-1
and X4V cells (P 	 0.0001). Panel D: [14C]Thymidine incorporation in xrcc4 (NHEJ-deficient) and xrcc4
 (control) cells. A decrease in colony-
forming efficiency is significantly linked to [14C]thymidine incorporation in XR-1 and X4V cells (P 	 0.0001). Toxicities at low doses are shown in
the insets. Scatter plots are combined data from at least three independent experiments.
Impact of the HR and NHEJ Pathways on Cell Survival
after Incorporation of Labeled Thymidine
RAD51 has been shown to control -ray-induced HR,
and dominant negative SMRAD51 has been shown to in-
hibit HR induced by  rays without increasing sensitivity
(13). At low doses (	1 Gy/nucleus), the HR-defective cells
(SMRAD51) showed a slight but significantly greater sen-
sitivity to incorporation of [3H]thymidine than did the wild-
type CHO-DRA10 cells (P 	 0.0001; Fig. 3A). However,
at higher doses (1 Gy/nucleus); i.e., in the second phase,
the two curves evolved in parallel, indicating that the HR-
defective cells were not more sensitive than wild-type cells
to higher doses from incorporated [3H]thymidine (Fig. 3A).
As a consequence, the calculated LD50 decreased from 3.24
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Gy/nucleus to 0.42 Gy/nucleus in the wild-type and HR-
deficient cells, respectively. Thus HR-deficient cells ap-
peared to be over sevenfold more sensitive to the incor-
porated of [3H]thymidine than were control cells. Impor-
tantly, sensitivity appeared to be due to low but not high
doses from incorporation [3H]thymidine.
For [14C]thymidine, the LD50 values were similar in wild-
type cells (mean  2.98 Gy/nucleus) and in HR-deficient
cells (mean  2.46 Gy/nucleus) (Fig. 3B). More specifi-
cally, the HR-defective cells (SMRAD51) were not more
sensitive to lower doses of [14C]thymidine (Fig. 3B), which
was consistent with [14C]thymidine failing to show in-
creased toxicity at lower doses.
HR-defective mutants are only moderately sensitive to
ionizing radiation. More specifically, SMRAD51-express-
ing cells are not sensitive to ionizing radiation, although
gene conversion is strongly impaired (13, 18). In contrast,
NHEJ-deficient mutants are highly sensitive to ionizing ra-
diation. Thus we measured the impact of incorporation of
labeled thymidine on the viability of the NHEJ-defective
XR-1 cells, which are mutated in the XRCC4 gene (Fig. 3C
and D).
While the wild-type CHO-DRA10 cells and the X4V
cells, which correspond to the mutant XR-1 complemented
with the XRCC4 cDNA, exhibited similar LD50 values
(compare Fig. 3C and D to Fig. 3A and B), the xrcc4
mutant cells showed a significantly greater sensitivity to
incorporated [3H]thymidine at both low and high doses (P
	 0.0001; Fig. 3C). At 0.97 Gy/nucleus, the viability of
xrcc4 mutant cells was only 10%, compared with 74% and
82% for X4V and CHO-DRA10 cells, respectively. The
LD50 decreased from a mean of 3.24 Gy/nucleus for X4V
or CHO-DRA10 cells to 0.23 Gy/nucleus for the XR-1 mu-
tant (xrcc4) (Fig. 3A and C). Thus xrcc4 cells are 15-
fold more sensitive to incorporated [3H]thymidine than con-
trol cells. Interestingly, although the NHEJ mutant is more
sensitive to ionizing radiation than HR-defective cells, their
sensitivities were similar to low doses from incorporated
[3H]thymidine (P  0.12). In contrast, strong differences
appeared at higher doses (compare Fig. 3A and B).
For [14C]thymidine, the mean LD50 was 2.67 Gy/nucleus
for the complemented cells and only 0.51 Gy/nucleus for
the xrcc4 mutant cells (Fig. 3D). This indicates that xrcc4
cells are five times more sensitive to the incorporated
[14C]thymidine than complemented cells (P 	 0.0001). In-
terestingly, comparisons of the LD50s revealed that
[3H]thymidine was twofold more toxic than [14C]thymidine
in XRCC4-defective cells (P 	 0.0001; compare Fig. 3C
and D).
Incorporated [3H] or [14C]Thymidine Induces Formation
of -H2AX Foci
Since cells deficient in DSB repair are sensitive to [3H]
or [14C]thymidine, it is conceivable that [3H] or
[14C]thymidine can induce DSBs. We therefore analyzed the
formation of -H2AX foci after incorporation of
[3H]thymidine at non-lethal doses (Fig. 4A). After genera-
tion of DSBs, H2AX is phosphorylated (-H2AX) and is
detectable as nuclear foci at the damaged sites (19, 20) in
a linear relationship with the number of induced DSBs (21).
The percentages of cells with -H2AX foci increased
significantly as a function of incorporated [3H] or
[14C]thymidine but required more than 0.16 Gy/nucleus and
0.11 Gy/nucleus, respectively, for detection above back-
ground levels (Fig. 4B to E). We then measured the mean
number of -H2AX foci per cell after [3H] or
[14C]thymidine incorporation. With  rays, there is a linear
relationship between the number of -H2AX foci and the
estimated number of DSBs (21). This allows us to extrap-
olate an estimate for [3H] or [14C]thymidine-induced DSBs.
Both the mean number of -H2AX foci/cells (Fig. 4B and
D) and the frequency of cells with -H2AX foci (Fig. 4C
and E) increased as a function of the incorporated dose.
Interestingly, the mean number of -H2AX foci was sig-
nificantly higher in NHEJ-defective cells than in comple-
mented cells (P 	 0.0001; Fig. 4D).
Foci form immediately after irradiation, after which they
disappear in a few hours due to DSB repair. In the present
work, -H2AX foci were analyzed at the end of the incu-
bation with labeled nucleotides (after 20 h incubation). The
frequencies of foci resulted from the countervailing influ-
ences of DSB repair (focus extinction) and the generation
of new DSBs (focus formation) at the time of monitoring
(i.e., the latest incubation times). The increased accumula-
tion of -H2AX foci in xrcc4-defective cells is consistent
with their DSB repair defect and accounts for their greater
sensitivity (see Fig. 3C and 3D). Taken together, these data
indicate that either [3H]thymidine or [14C]thymidine can in-
duce DSBs, which are processed by the XRCC4 pathway.
In contrast, SMRAD51 cells did not show significantly
more -H2AX foci compared with wild-type cells (Fig.
4B), which is consistent with these cells being not sensitive
to the high doses of labeled nucleotides required to induce
-H2AX foci (see Fig. 3A and 3B).
Incorporation of Non-lethal Levels of [3H] or
[14C]Thymidine Strongly Stimulates the RAD51 Gene
Conversion HR Pathway
Ionizing radiation and DSBs stimulate HR in p53 cells
(12, 13, 22, 23). In the CHO-DRA10 cells used here, 
rays stimulated HR (13) at highly toxic doses (compare Fig.
5A and B). Indeed,  rays significantly induced HR, but
only at doses resulting in 10% to 20% survival (Fig. 5B).
In contrast, incorporation of [3H]thymidine and
[14C]thymidine strongly stimulated HR at doses leading to
survivals between 60% and 100% (compare Figs. 5C and
D and 3A and B). Consistent with its higher toxicity at
lower doses, [3H]thymidine stimulated HR at lower doses
than 14C (P 	 0.0001) and then reached a plateau that was
at least twofold higher with [3H]thymidine than with
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FIG. 4. -H2AX foci induced by [3H] or [14C]thymidine. Panel A: Example of -H2AX foci (contamination of
CHO-DRA10 with [3H]thymidine at 1.29 Gy/nucleus). Panel B: Mean number of -H2AX foci per cell as a function
of the incorporated dose in CHO-DRA10 and SMRAD51 cells. The mean number of -H2AX foci per cell is
significantly linked to [3H]thymidine incorporation (left frame; P 	 0.0001) and [14C]thymidine incorporation (right
frame; P 	 0.0001) in CHO-DRA10 and SMRAD51 cells. Panel C: Percentage of cells with -H2AX foci as a
function of the incorporated dose in CHO-DRA10 and SMRAD51 cells. The percentage of -H2AX foci is signif-
icantly linked to both [3H]thymidine incorporation (left frame) and [14C]thymidine incorporation (right frame) in
CHO-DRA10 and SMRAD51 cells (P 	 0.0001). Panel D: Mean number of -H2AX foci per cell as a function of
the incorporated dose in XR-1 and X4V cells. The mean number of -H2AX foci per cell is significantly linked to
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both [3H]thymidine incorporation (left frame) and [14C]thymidine incorporation (right frame) in XR-1 and X4V cells
(P 	 0.0001). Panel E: Percentage of cells with -H2AX foci as a function of the incorporated dose in XR-1 and
X4V cells. The percentage of -H2AX foci is significantly linked to both [3H]thymidine incorporation (right frame)
and [14C]thymidine incorporation (left frame ) in XR-1 and X4V cells (P 	 0.0001). More than 100 nuclei were
scored for each labeled thymidine incorporation. Scatter plots are combined data from at least three independent
experiments.
[14C]thymidine (Fig. 5C). For doses resulting in comparable
levels of viability (60 to 100%), no -ray-induced HR was
recorded. Moreover, the maximum HR stimulation pro-
duced by a -ray dose resulting in 10% survival (6 Gy)
was very low compared with the HR stimulation induced
by non-lethal doses.
SMRAD51 has been shown to efficiently inhibit the in-
duction of HR by  rays (13). We also found that
SMRAD51 completely abolished HR induced by incorpo-
ration of labeled thymidine (Fig. 5C and D).
After genotoxic stress, the pivotal HR protein RAD51 as-
sembles into nuclear foci at DNA damage sites, which are
thought to represent recombination/repair centers (16, 19, 24,
25). RAD51 focus assembly seems to be a prerequisite for
HR, because no HR events had been recorded previously
when RAD51 assembly was impaired. We found here that
[3H]thymidine incorporation leads to RAD51 focus assembly
(Fig. 6A). RAD51 foci were detectable at a dose of 0.09 Gy/
nucleus (3  104 dpm/106 cells) and reached a plateau, with
50% of cells containing RAD51 foci at 0.32 Gy/nucleus. The
dose–response curves for RAD51 focus assembly were con-
sistent with those for induction of HR (compare Fig. 6B and
5C). Taken together, these data suggest that low doses from
incorporation [3H]thymidine stimulate the RAD51-dependent
gene conversion pathway.
DISCUSSION
In this work, we analyzed the impact of incorporation of
[3H] or [14C]thymidine at the molecular level when a precise
subcellular compartment, the nucleus, was targeted. Impor-
tantly, the relative impact of [3H]thymidine compared with
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FIG. 5. Effects of  rays and [3H] or [14C]thymidine incorporation on homologous recombination. Panel A:
Survival of CHO-DRA10 after  irradiation. Panel B: induction of HR by  rays. Panel C: HR induction as a
function of [3H]thymidine incorporation. Impact of overexpression of the dominant negative form of RAD51,
SMRAD51, on HR induced by incorporated [3H]thymidine. For CHO-DRA10 cells, the increase in HR is significantly
linked to [3H]thymidine incorporation (P 	 0.0001). Panel D: Induction of HR as a function of [14C]thymidine
incorporation. Impact of overexpression of SMRAD51 on HR induced by incorporated [14C]thymidine. For CHO-
DRA10 cells, increase in HR is significantly linked to [14C]thymidine incorporation (P 	 0.0001). Scatter plots are
combined data from at least three independent experiments.
[14C]thymidine incorporation depends on the dose and reveals
a ‘‘low-dose’’ effect. Although the LD50s were similar,
[3H]thymidine was more toxic than [14C]thymidine at lower
doses. In addition, we demonstrated that XRCC4- and
RAD51-dependent pathways respond to incorporation of ra-
dioactivity by mammalian cells. Importantly, HR-defective
cells showed increased sensitivity to lower doses from incor-
porated [3H]thymidine but not to either  rays or high doses
from incorporated [3H]thymidine. In contrast, HR-defective
cells do not appear to be hypersensitive to low doses of
[14C]thymidine, consistent with the fact that this compound
does not generate a ‘‘low-dose’’ effect. Importantly, the sen-
sitivity to low doses of [3H]thymidine in HR-defective cells
is similar to that of NHEJ-defective cells. The larger differ-
ence in viabilities between HR- and NHEJ-defective cells is
revealed at high doses. Indeed, the sensitivity of HR-defective
cells is restricted to low 3H doses, while NHEJ-defective cells
are sensitive to both low and high 3H doses as well as to 
rays. Thus the present work reveals a specific effect of low
doses of low-energy incorporated isotopes on survival. The
greater toxicity recorded in the HR mutant at low doses from
incorporated [3H]thymidine demonstrate that the HR pathway
plays a major role in repair of damages induced by tritium
disintegration.
Finally, we show that incorporation of [3H]thymidine,
and to a lesser extent [14C]thymidine, strongly stimulates
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FIG. 6. [3H]Thymidine-induced RAD51 foci. Panel A: Example of RAD51 foci. Panel B: RAD51 focus formation
as a function of the incorporated dose. The mean number of RAD51 foci per cell is significantly linked to
[3H]thymidine incorporation (P 	 0.0001). Data from at least three independent experiments.
HR, even without cell mortality. Such HR stimulation can-
not be achieved with  rays, because they kill cells. HR
induced by [3H]uracil occurs after relatively little tritium
decay in Saccharomyces cerevisiae. However, in contrast
to what was observed here in mammalian cells, [3H]uracil
induces cell death and gene conversion at levels that are
similar to those produced by an equivalent dose of  ra-
diation in S. cerevisiae (10).
The risks for damage increase when the energy emitted
by the radionuclide decreases. This can be explained by the
fact that more total energy is deposited into the nucleus by
a low-energy compound. Indeed, [3H]thymidine (0.019
MeV), which deposits 68% of its energy in the nucleus, is
more toxic and stimulates HR more efficiently than
[14C]thymidine (0.157 MeV), which deposits only 19% of
its energy in the nucleus (1). This underscores the fact that
the energy deposited into the nucleus is an essential para-
metric determinant of cell viability and genetic alteration
after uptake of radioactive compounds and may be respon-
sible for the toxicity and genetic effects at lower doses.
DSBs are highly toxic lesions that can be induced by
ionizing radiations. Two mechanisms can repair DSBs:
NHEJ and HR. NHEJ-defective cells are highly sensitive
to ionizing radiation (26, 27). The fact that NHEJ mutant
cells show increased sensitivity supports the model that in-
corporated [3H] or [14C]thymidine produces DSBs in the
DNA. This conclusion is also supported by the formation
of -H2AX foci upon incorporation of [3H] or
[14C]thymidine. Alternatively, cells can take advantage of a
homologous sequence to repair DSBs by HR processes.
Ionizing radiations, and more specifically DSBs, stimulate
HR in mammalian cells (12, 13, 22, 23) in a RAD51-de-
pendent manner (13). Similarly, we showed here that la-
beled nucleotide incorporation stimulates HR and, among
the different processes (28), gene conversion, which is a
RAD51-dependent pathway (13, 29–31). Taken together,
these data are consistent with the idea that incorporated
labeled nucleotides, even at non-lethal levels, cause geno-
toxic stress involving DSB production and gene conversion.
HR is essential to maintaining genome stability. How-
ever, HR should be precisely regulated, because an excess
in HR can also result in chromosomal instability and dis-
ease (32–34). Indeed, recombination between repeated se-
quences dispersed throughout the genome can lead to de-
letions, amplifications, translocations or inversions (35).
Overexpression of RAD51, which stimulates HR (13, 36–
38), has been reported in tumor cells (39, 40). Excess HR
also has been reported in different precancerous situations,
such as defects in p53 (35), ataxia telangiectasia (41) and
expression of the oncogene kinase BCR-ABL (Philadelphia
chromosome) involved in acute myeloid leukemia (42). In
addition, accumulation of unprocessed HR intermediates
leads to cytotoxicity and genomic instability (43, 44). These
results emphasize the potential dangers of excess HR. On
the basis of these considerations, the results presented here
showing strong RAD51-HR stimulation in the absence of
cell toxicity reveal a potential health risk from contamina-
tion, even at non-cytotoxic exposure levels.
Treatment with  rays produces DSBs and induces HR,
but this induction is correlated with a marked decrease in
cell viability. In asynchronous cells, -ray doses leading to
80% cell survival do not induce measurable HR. In con-
trast, low doses from incorporated [3H] or [14C]thymidine
strongly induce HR. Incorporation of labeled nucleotide re-
sults in self-irradiation of DNA, with most of the energy
deposited locally (i.e. in the DNA and in the nucleus). In
contrast, -ray energy is deposited all along the paths and
subcellular compartments that are crossed by the  rays
(e.g. membranes and the cytoplasm). It is likely that irra-
diation of subcellular compartments increases toxicity. In
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addition, all the energy from  rays is deposited during a
limited period (2 Gy/min), whereas the cells used here were
exposed to labeled nucleotides for several hours. The dif-
ference in survival might reflect a dose-rate effect. More-
over, treatment with [3H]thymidine has been shown to pro-
tect against chromosomal instability induced by high doses
of ionizing radiation, a process called the adaptive response
(45). A microdosimetric model shows that the adaptive re-
sponse works at very low doses. Indeed, in this model, the
specific energy from single charged particles that hits the
nucleus can activate the adaptive response (46). Since we
have shown here that low doses of [3H]thymidine induce
HR, and since HR protects against genome instability, we
speculate that HR may participate in the adaptive response.
In the present experiments, tritium was coupled to a nu-
cleotide (thymidine), which is a DNA precursor. This sit-
uation is quite different from the intake of tritiated water,
and the question arises as to the potential effect of low
radiation doses from tritiated water. Cell lethality and chro-
mosome aberrations have been recorded with tritiated water
(3, 8, 47, 48). Moreover, sister chromatid exchanges were
induced in bone marrow cells of mice treated with tritiated
water (49), showing that DNA damage is induced by triti-
ated water. Finally, induction of HR by tritiated water has
been described in S. cerevisiae (11).
In conclusion, incorporation of radioactive compounds
into DNA leads efficiently to genomic rearrangements, with
increased risks with lower-energy isotopes. The absence of
cell toxicity represents an additional danger for multicel-
lular organisms since the survival of cells carrying genomic
rearrangements increases oncogenic risks. The ability of in-
corporated radioactivity to induce recombination without
killing cells may have some bearing on the induction and
transgenerational transmission of genetic alterations after
contamination with radioisotopes.
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